---
annotation-target: s12943-022-01640-7.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-13T05:39:01.841Z","updated":"2022-09-13T05:39:01.841Z","document":{"title":"PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma","link":[{"href":"urn:x-pdf:850a120f09fb90a1b020cf5526c0bda2"},{"href":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf"}],"documentFingerprint":"850a120f09fb90a1b020cf5526c0bda2"},"uri":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","selector":[{"type":"TextPositionSelector","start":928,"end":1037},{"type":"TextQuoteSelector","exact":"Anaplastic large cell lymphoma (ALCL) is an aggressive non‑Hodgkin T cell lymphoma commonly driven by NPM‑ALK","prefix":"0,11,30*† Abstract Background:  ","suffix":". AP‑1 transcription factors, cJ"}]}]}
>```
>%%
>*%%PREFIX%%0,11,30*† Abstract Background:%%HIGHLIGHT%% ==Anaplastic large cell lymphoma (ALCL) is an aggressive non‑Hodgkin T cell lymphoma commonly driven by NPM‑ALK== %%POSTFIX%%. AP‑1 transcription factors, cJ*
>%%LINK%%[[#^5chz6lj7he3|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^5chz6lj7he3


>%%
>```annotation-json
>{"created":"2022-09-13T05:40:49.922Z","updated":"2022-09-13T05:40:49.922Z","document":{"title":"PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma","link":[{"href":"urn:x-pdf:850a120f09fb90a1b020cf5526c0bda2"},{"href":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf"}],"documentFingerprint":"850a120f09fb90a1b020cf5526c0bda2"},"uri":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","selector":[{"type":"TextPositionSelector","start":1160,"end":1322},{"type":"TextQuoteSelector","exact":" Blocking PDGFRβ kinase activity with imatinib effectively reduces tumor burden and prolongs survival, although the downstream molecular mechanisms remain elusive","prefix":"n‑scriptionally regulate PDGFRβ.","suffix":".Methods and results:  In a tran"}]}]}
>```
>%%
>*%%PREFIX%%n‑scriptionally regulate PDGFRβ.%%HIGHLIGHT%% ==Blocking PDGFRβ kinase activity with imatinib effectively reduces tumor burden and prolongs survival, although the downstream molecular mechanisms remain elusive== %%POSTFIX%%.Methods and results:  In a tran*
>%%LINK%%[[#^42xfeg1p4ga|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^42xfeg1p4ga


>%%
>```annotation-json
>{"created":"2022-09-13T05:45:25.747Z","updated":"2022-09-13T05:45:25.747Z","document":{"title":"PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma","link":[{"href":"urn:x-pdf:850a120f09fb90a1b020cf5526c0bda2"},{"href":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf"}],"documentFingerprint":"850a120f09fb90a1b020cf5526c0bda2"},"uri":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","selector":[{"type":"TextPositionSelector","start":3412,"end":3807},{"type":"TextQuoteSelector","exact":"PDGFRβ-STAT5 activity, acting in parallel to the NPM-ALK-STAT3  signaling  axis,  correlates  with  an  inferior  Event  Free  Survival  (EFS)  and  Cumulative  Incidence of Relapse (CI-R) in ALCL.•  PDGFRβ  induced  STAT5  activity,  increases  prolif-eration  by  stimulating  IL-10  secretion  and  block-ing  apoptosis  by  upregulating  Bcl-xL,  characterizing  PDGFRβ as a novel biomarker.","prefix":"t line to the data.Key points•  ","suffix":"Open Access†S. Lagger and L. Ken"}]}]}
>```
>%%
>*%%PREFIX%%t line to the data.Key points•%%HIGHLIGHT%% ==PDGFRβ-STAT5 activity, acting in parallel to the NPM-ALK-STAT3  signaling  axis,  correlates  with  an  inferior  Event  Free  Survival  (EFS)  and  Cumulative  Incidence of Relapse (CI-R) in ALCL.•  PDGFRβ  induced  STAT5  activity,  increases  prolif-eration  by  stimulating  IL-10  secretion  and  block-ing  apoptosis  by  upregulating  Bcl-xL,  characterizing  PDGFRβ as a novel biomarker.== %%POSTFIX%%Open Access†S. Lagger and L. Ken*
>%%LINK%%[[#^hx9gga5z1mk|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^hx9gga5z1mk


>%%
>```annotation-json
>{"created":"2022-09-13T05:45:40.295Z","updated":"2022-09-13T05:45:40.295Z","document":{"title":"PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma","link":[{"href":"urn:x-pdf:850a120f09fb90a1b020cf5526c0bda2"},{"href":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf"}],"documentFingerprint":"850a120f09fb90a1b020cf5526c0bda2"},"uri":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","selector":[{"type":"TextPositionSelector","start":4147,"end":4340},{"type":"TextQuoteSelector","exact":"ombined  loss  of  STAT5A  and  STAT5B  is  lethal  in   ALK+ ALCL, suggesting STAT5 as a valid therapeu-tic  target  that  can  be  successfully  inhibited  with  the  STAT inhibitor AC-4-130.","prefix":"ncer          (2022) 21:172 •  C","suffix":"IntroductionAnaplastic  Large  C"}]}]}
>```
>%%
>*%%PREFIX%%ncer          (2022) 21:172 •  C%%HIGHLIGHT%% ==ombined  loss  of  STAT5A  and  STAT5B  is  lethal  in   ALK+ ALCL, suggesting STAT5 as a valid therapeu-tic  target  that  can  be  successfully  inhibited  with  the  STAT inhibitor AC-4-130.== %%POSTFIX%%IntroductionAnaplastic  Large  C*
>%%LINK%%[[#^2espd42meb2|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^2espd42meb2


>%%
>```annotation-json
>{"created":"2022-09-13T05:50:33.801Z","updated":"2022-09-13T05:50:33.801Z","document":{"title":"PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma","link":[{"href":"urn:x-pdf:850a120f09fb90a1b020cf5526c0bda2"},{"href":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf"}],"documentFingerprint":"850a120f09fb90a1b020cf5526c0bda2"},"uri":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/s12943-022-01640-7.pdf","selector":[{"type":"TextPositionSelector","start":32569,"end":32668},{"type":"TextQuoteSelector","exact":"STAT5 plays an essential role in maintaining self-renewal  capacities  of  hematopoietic  cells  vi","prefix":"es apoptosis of  ALK+ ALCL cells","suffix":"a  the  tight  Fig. 3 PDGFRβ act"}]}]}
>```
>%%
>*%%PREFIX%%es apoptosis of  ALK+ ALCL cells%%HIGHLIGHT%% ==STAT5 plays an essential role in maintaining self-renewal  capacities  of  hematopoietic  cells  vi== %%POSTFIX%%a  the  tight  Fig. 3 PDGFRβ act*
>%%LINK%%[[#^5y8h7gl5ywq|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^5y8h7gl5ywq
